Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
60.77
+1.04 (1.74%)
At close: Aug 21, 2026, 4:00 PM EDT
60.60
-0.17 (-0.28%)
Pre-market: Aug 24, 2026, 6:26 AM EDT
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $5.88 billion as of August 24, 2026. Its market cap has increased by 102.77% in one year.
Market Cap
5.88B
Enterprise Value
4.65B
1-Year Change
102.77%
Ranking
Category
Stock Price
$60.77
ChartMarket Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $5.88B, an increase of 4,038.53%. That is a compound annual growth rate of 37.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 5.89B | 69.91% |
| Dec 31, 2025 | 3.46B | 15.89% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
| Nov 5, 2014 | 142.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.49B |
| Cogent Biosciences | 6.38B |
| Mirum Pharmaceuticals | 6.25B |
| Dianthus Therapeutics | 6.21B |
| Travere Therapeutics | 6.19B |
| Erasca | 6.17B |
| Definium Therapeutics | 6.03B |
| PTC Therapeutics | 5.83B |